Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer
Laura Díaz-Gil(Instituto de Investigación Biomédica de Salamanca), Atanasio Pandiella(Complejo Hospitalario Universitario de Albacete)
Cited by 9
Related Papers
Effect of Multikinase Inhibitors on Caspase-Independent Cell Death and DNA Damage in HER2-Overexpressing Breast Cancer Cells
|JNCI Journal of the National Cancer Institute|2010|48
Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2022|23
Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2
|Oncotarget|2015|19
An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
|Journal of Experimental & Clinical Cancer Research|2023|10